Adagene Inc
$ 4.11
-0.72%
07 Aug - close price
- Market Cap 271,558,000 USD
- Current Price $ 4.11
- High / Low $ 4.34 / 4.01
- Stock P/E N/A
- Book Value 0.75
- EPS -0.37
- Next Earning Report -
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.16 %
- ROE -0.34 %
- 52 Week High 4.85
- 52 Week Low 1.30
About
Adagene Inc., a clinical-stage biopharmaceutical company, is dedicated to the research, development, and production of monoclonal antibody drugs for cancer. The company is headquartered in Suzhou, China.
Analyst Target Price
$10.74
Quarterly Earnings
| Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-04-01 | 2025-12-03 | 2025-08-12 | 2025-05-28 | 2025-03-24 | 2024-11-27 | 2024-07-25 | 2024-05-29 | 2024-03-29 | 2023-11-29 | 2023-08-31 | 2023-04-28 |
| Reported EPS | 0 | 0 | -0.23 | -0.17 | -0.29 | 0 | -0.285 | 0 | -0.27 | -0.42 | -1.48 | -0.15 |
| Estimated EPS | -0.21 | -0.18 | -0.33 | -0.17 | -0.47 | 0 | -0.26 | 0 | -0.27 | -0.42 | -0.93 | -0.36 |
| Surprise | 0.21 | 0.18 | 0.1 | 0 | 0.18 | 0 | -0.025 | 0 | 0 | 0 | -0.55 | 0.21 |
| Surprise Percentage | 100% | 100% | 30.303% | 0% | 38.2979% | None% | -9.6154% | None% | 0% | 0% | -59.1398% | 58.3333% |
Next Quarterly Earnings
| Reported Date |
| Fiscal Date Ending |
| Estimated EPS |
| Currency |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: ADAG
2026-08-07 23:09:50
Adagene (NASDAQ:ADAG) CEO Peter Luo recently increased his holdings in the company by purchasing 22,966 shares at an average price of $3.65, totaling approximately $83,826. This transaction, along with an additional purchase of 279 shares the following day, boosted his ownership by 51.04%. Despite a mixed analyst sentiment, with a consensus "Moderate Buy" rating and an $8.50 price target, the stock traded down 2.1% on Thursday.
2026-08-07 23:09:50
This page provides an interactive stock chart and related news for Adagene Inc. (ADRs) under the ticker US0053291078.SG on Yahoo Finance. The stock is currently trading at 3.7800 EUR
2026-08-07 23:09:50
Adagene CEO Peter Luo has purchased 23,245 American Depositary Shares (ADS) at approximately $3.65 per share, totaling $84,763.97. Following this transaction, his directly held ADS position increased to 68,245 shares, in addition to 112,500 restricted stock units. This information was generated using AI based on an SEC filing by Adagene Inc.
2026-07-29 21:05:20
This article provides a financial overview of Adagene Inc. (ADAG), including real-time stock quotes, market capitalization, and a detailed breakdown of its financial statements. It highlights the company's latest earnings report for FY2025, showing revenue of 7.67M and an EPS of -0.37, alongside various financial indicators and trends over recent periods. The data dashboard allows investors to analyze income statements, balance sheets, and cash flow statements for informed decision-making.
2026-07-28 00:11:06
This article provides a technical analysis of Adagene Inc (ADAG), detailing its support, resistance, indicators, and moving averages. According to the analysis, the overall signal based on moving averages and other technical indicators is "Neutral", despite showing 6 buy signals for moving averages and 0 buy signals for general technical indicators. The article emphasizes that technical analysis is for reference only and not financial advice.
2026-07-27 18:10:44
This article provides a valuation analysis for Adagene Inc (ADAG), focusing on key metrics like P/E, P/B, P/S, and P/CF ratios. The report indicates that relevant data for these valuation metrics have not yet been disclosed by the company. It briefly shows the current stock price and market capitalization for ADAG.
